Dihydroartemisinin-piperaquine
Dihydroartemisinin-piperaquine is a pharmaceutical drug with 50 clinical trials. Currently 4 active trials ongoing. Historical success rate of 97.6%.
Success Metrics
Based on 40 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
7
Mid Stage
33
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
97.6%
40 of 41 finished
2.4%
1 ended early
4
trials recruiting
50
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community Transmission
Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials
Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi
Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia
Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy
Clinical Trials (50)
Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community Transmission
Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials
Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi
Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia
Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy
The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy
Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates
Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania
Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities
Intermittent Preventive Treatment of Malaria in Schoolchildren
Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda
Comparing Chemoprevention Drugs for School-based Malaria Control
Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in Tanzania
Compare the Effectiveness Between Existing Treatment and New Treatment
Comparing Chemoprevention Approaches for School-based Malaria Control
Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa
Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)
Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy
Adjunctive Ivermectin Mass Drug Administration for Malaria Control
Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 50